Home > PS Ratio > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of SUVEN PHARMACEUTICALS is 26.38.

Share Price ₹1,086.3Apr 04,2025
Market Cap ₹27,657.2 Cr
Sales-TTM₹1,048.5 CrTTM-Consolidated Results
Price/Sales26.38xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SUVEN PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SUVEN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹27,657.2 Cr] as on Apr 04,2025

(/) Sales [ ₹1,048.5 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 26.38x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay '26.38 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of SUVEN PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of SUVEN PHARMACEUTICALS


PS Ratio Performance Analysis for SUVEN PHARMACEUTICALS

- SUVEN PHARMACEUTICALS 's latest p/e ratio is 26.38x.

- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 10.57x.

- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 11.92x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 16.38x.

- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 3.08x.


How does SUVEN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SUVEN PHARMACEUTICALS 1,048.526.3827,657.2
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.95410,142.0
DIVIS LABORATORIES LTD9,078.016.06145,762.0
CIPLA LTD26,981.24.24114,322.0
TORRENT PHARMACEUTICALS LTD11,302.09.84111,171.0
DR REDDYS LABORATORIES LTD31,229.32.9792,603.7
MANKIND PHARMA LTD11,641.08.68101,098.0
ZYDUS LIFESCIENCES LTD22,247.43.9287,205.3
LUPIN LTD22,001.64.0989,993.5
AUROBINDO PHARMA LTD30,921.82.0864,167.0
ABBOTT INDIA LTD6,243.29.8961,727.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.08x
Max industry PS 26.38x
Median industry PS 7.95x
Average industry PS 8.73x



You may also like the below Video Courses